BSE · 542803
Vaxfab Enterprises Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹0 Cr with net profit ₹-6 Cr — a -1460% net margin, versus 56.85% the period before.
Shareholding
As of 2026-09-30
- Public99.96%
- FII0.04%
2,921 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
Not enough history.
52-week position
Where the current price sits in its yearly band
The band spans 2.11× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Trading · ranked #166 of 693 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Adani Enterprises Limited | ₹3,63,802 Cr | 101.43 | 3.71 | 3.66% | 4.59% |
| Avenue Supermarts Limited | ₹2,24,349 Cr | 71.98 | 8.6 | 11.94% | 4.2% |
| Trent Ltd. | ₹1,68,779 Cr | 88.12 | 21.69 | 24.4% | 8.62% |
| FSN E-Commerce Ventures Ltd. | ₹1,04,618 Cr | 314.83 | 63.16 | 19.49% | 2.85% |
| Aditya Infotech Limited | ₹50,886 Cr | 82.37 | 13.87 | 16.16% | 10.38% |
| Vishal Mega Mart Limited | ₹45,148 Cr | 50.19 | 5.7 | 11.37% | 6.45% |
| Aegis Logistics Limited | ₹42,976 Cr | 32.26 | 6.45 | 20.01% | 14.99% |
| Premier Energies Limited | ₹40,670 Cr | 22.98 | 7.88 | 34.23% | 19.11% |
| Redington Limited | ₹27,339 Cr | 13.62 | 2.54 | 18.62% | 1.31% |
| Honasa Consumer Limited | ₹16,378 Cr | 57.17 | 11.02 | 19.03% | 10.3% |
| Vaxfab Enterprises Limited(this company) | ₹170 Cr | — | 4.7 | -10.6% | -13.6% |
AI analysis
AI-generated · google/gemini-2.5-flashVaxfab Enterprises Limited has a market capitalization of Rs 153 Cr. The company reported revenue of Rs 16.75 Cr, with a negative profit margin of -353.5%. The debt-to-equity ratio is low at 0.02. The promoter holding is 0%, with public shareholding at 99.9%. The company's 52-week high was Rs 68 and its 52-week low was Rs 16.65. The stock is currently under LT-ASM (Additional Surveillance Measure) Stage 1.
Positives
- +The debt-to-equity ratio is low at 0.02, indicating minimal reliance on borrowed capital.
- +The number of shareholders has increased to 2977 in May 2026 from 513 in March 2020.
Negatives
- −The company reported a negative profit margin of -353.5%, indicating significant losses.
- −The Return on Equity (ROE) is negative at -10.6%, and Return on Capital Employed (ROCE) is also negative at -3.441%.
- −Promoter holding is 0% as of May 2026, a decrease from 25.7708% in March 2021.
- −The stock is under LT-ASM (Additional Surveillance Measure) Stage 1, which signifies potential price volatility or unusual trading activity.
- −There are no quarterly results disclosed since Dec 2025.
Financial Performance
In the latest annual reporting period, Vaxfab Enterprises Limited recorded a revenue of Rs 8.83 Cr in Mar 2026. Quarterly revenue for Dec 2025 was Rs 15.66 Cr, with a net profit of -3.24 Cr. The company's annual revenue for Mar 2025 was Rs 58.67 Cr, generating a net profit of Rs 0.7 Cr for that period.
Profitability & Returns
Vaxfab Enterprises Limited reported a negative Return on Equity (ROE) of -10.6% and a negative Return on Capital Employed (ROCE) of -3.441%. The company's profit margin stood at -353.5%. The earnings per share (EPS) for the latest period was 0.
Balance Sheet
The company maintains a low debt-to-equity ratio of 0.02. The book value per share is Rs 13.94. No dividend yield was reported for the current period.
Ownership & Pledges
As of May 31, 2026, promoter shareholding is 0%, while public shareholding stands at 99.9%. The number of shareholders is 2977. There are no reported promoter pledges.
Regulatory & Surveillance
Vaxfab Enterprises Limited is currently under LT-ASM (Additional Surveillance Measure) Stage 1, indicating increased scrutiny due to specific market parameters.
Data as of — price: 2026-11-14 · financials: Jun 26 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Vaxfab Enterprises Limitedshare price & fundamentals